Skip to search.
 FTSE 100 Up 0.57%

VIVUS Inc. (VVUS)

-NasdaqGS
1.19 Down 0.01(0.84%) 16:21 - Nasdaq Real Time Price
Prev Close:1.20
Open:1.22
Bid:1.20 x 10600
Ask:1.21 x 4000
1y Target Est:10.40
Beta:0.231973
Earnings Date:2 Nov - 7 Nov (Est.)
Day's Range:1.18 - 1.22
52wk Range:0.92 - 2.25
Volume:117,554
Avg Vol (3m):378,488
Market Cap:123.97m
P/E (ttm):N/A
EPS (ttm):-0.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for VVUS at this time.

Comparison

Symbol% ChgMkt Cap
VVUSDown 0.84%123.97m
LLYDown 0.79%84.67b
PFEDown 0.15%204.90b
GSKUp 0.30%103.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.64
Quarterly EPS Est (Sep-16) :-0.20
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-2.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback